In HCC, tumour cells can promote the expression of pro‐proliferative genes and inhibit cell cycle inhibitory molecules to promote proliferative capacity via the IDO1‐AHR‐β‐catenin pathway.175. This evidence concerns the gene IDO1 and neoplasm.